Delivery Order SPE2DR25D9353-SPE2DR26FQWP6
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $46,509.80 to DMS Pharmaceutical Group Inc. for Perjeta 420 mg/14 ml vials, a oncology therapeutic product. The order was awarded on December 11, 2025, with an ultimate completion date of January 5, 2026, under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform work at its Park...
- The Defense Logistics Agency awarded a delivery order valued at $4,650.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. The contract, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,905.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. The delivery order, issued on January 16, 2026, with an ultimate completion date of February 9, 2026, operates under a firm fixed-price arrangement with no set-aside designation. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery...
- The Defense Logistics Agency awarded a $79,430.86 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Perjeta 420 mg/14 mL vials. The award, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, carries no set-aside designation and was issued without subcontractor involvement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $19,623.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. This firm fixed-price delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, indicating the award was made through unrestricted competition. The product will be delivered to Park...
- The Defense Logistics Agency awarded a $58,869.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. The delivery order was issued on January 12, 2026, with an ultimate completion date of February 3, 2026, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order valued at $4,905.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. The delivery order, issued on January 2, 2026, with an ultimate completion date of January 26, 2026, operates under a firm fixed-price contract structure with no set-aside designation. This award falls under DMS Pharmaceutical Group's Pharmaceutical Prime...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $46,509.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. The award was issued on November 13, 2025, with an ultimate completion date of December 5, 2025, and carries no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $58,869.72 to DMS Pharmaceutical Group Inc. for the supply of Perjeta 420 mg/14 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled for ultimate completion by February...
- The Defense Logistics Agency awarded a delivery order valued at $70,298.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta (420 mg/14 mL vials). This firm fixed-price delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- SPE2DR25D9353Indefinite Delivery Contract
- SPE2DR25D9353-SPE2DR26FQWP6Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for Perjeta 420 mg/14 ml vials with a ceiling value of $4,905.81, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The parent contract, SPE2DR, is a single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036, authorizing DLA to issue firm fixed-price delivery orders for pharmaceutical products to support Department of Defense healthcare operations worldwide. Place of performance is Park Ridge, IL 60068. The delivery order has an ultimate completion date of March 2, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 2/5/26 |